We are live on ! Find out more
NRXPW

NRX Pharmaceuticals Warrant
NRXPW

Delisted

NRXPW was delisted on the 22nd of May, 2026.

Back to rankings

13 hedge funds and large institutions have $753K invested in NRX Pharmaceuticals Warrant in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

19% more capital invested

Capital invested by funds: $635K → $753K (+$118K)

8% more funds holding

Funds holding: 12 → 13 (+1)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
13
Holders Change
+1
Holders Change %
+8.33%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
Bulldog Investors
New Jersey
+$49.1K
2
WCMNY
Westchester Capital Management (New York)
New York
+$48K
3
KPF
K2 Principal Fund
Ontario, Canada
+$39.7K
4
6CM
683 Capital Management
New York
+$32.4K
5
PC
Periscope Capital
Ontario, Canada
+$19.8K

Top Sellers

Rank Fund Capital Flow
1
PGC
Pacific Grove Capital
California
-$20K
2
WRBC
W.R. Berkley Corp
Connecticut
-$15K
3
DAM
Deltec Asset Management
New York
-$12K
4
GCL
Glazer Capital LLC
New York
-$9.34K
5
HIM
HGC Investment Management
Ontario, Canada
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
1
Boothbay Fund Management
New York
$334K – – –
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$74K – – –
OAM
3
Oxford Asset Management
United Kingdom
$47K – – –
WCMNY
4
Westchester Capital Management (New York)
New York
$46K +$48K +122,379 New
AA
5
AQR Arbitrage
Connecticut
$45K – – –
BI
6
Bulldog Investors
New Jersey
$41K +$49.1K +125,000 New
6CM
7
683 Capital Management
New York
$37K +$32.4K +82,500 New
KPF
8
K2 Principal Fund
Ontario, Canada
$33K +$39.7K +101,200 New
YCM
9
Yakira Capital Management
Connecticut
$31K – – –
GCL
10
Glazer Capital LLC
New York
$21K -$9.34K -23,800 -27%
VAS
11
VR Advisory Services
Cayman Islands
$20K +$17.5K +44,607 New
PC
12
Periscope Capital
Ontario, Canada
$19K +$19.8K +50,400 New
BCM
13
Basso Capital Management
Connecticut
$5K – – –
PGC
14
Pacific Grove Capital
California
– -$20K -50,000 Closed
WRBC
15
W.R. Berkley Corp
Connecticut
– -$15K -36,393 Closed
DAM
16
Deltec Asset Management
New York
– -$12K -28,350 Closed
HIM
17
HGC Investment Management
Ontario, Canada
– -$4K -9,962 Closed

NRXPW Hedge Fund Activity: Q1 2018 in Review

13 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in NRX Pharmaceuticals Warrant (NRXPW) for Q1 2018, worth a combined $753K — up 19% from $635K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NRXPW positions and 5 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Bulldog Investors, opening a new position worth an estimated $49.1K. The largest seller was Pacific Grove Capital, exiting entirely with an estimated $20K sold.

  • 13 institutional investors held NRX Pharmaceuticals Warrant (NRXPW) as of Q1 2018, up from 12 in Q4 2017.
  • Funds reported $753K of NRX Pharmaceuticals Warrant stock for Q1 2018, up 19% quarter-over-quarter.
  • 6 funds opened new NRX Pharmaceuticals Warrant positions in Q1 2018 and 5 closed out, a net change of +1 holder.
  • The largest NRX Pharmaceuticals Warrant buyer in Q1 2018 was Bulldog Investors, an estimated $49.1K added.
  • The largest NRX Pharmaceuticals Warrant seller in Q1 2018 was Pacific Grove Capital, an estimated $20K sold.

Based on aggregated 13F filings for Q1 2018.